• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Renin-angiotensin-aldosterone system inhibitors as a risk factor for chronic subdural hematoma recurrence: A matter of debate.

作者信息

Shimohigoshi Wataru, Takase Hajime, Haze Tatsuya, Kobayashi Yusuke, Manaka Hiroshi, Kawasaki Takashi, Sakata Katsumi, Yamamoto Tetsuya

机构信息

Department of Neurosurgery, Yokohama City University Medical Center, Yokohama, Japan.

Center for Novel and Exploratory Clinical Trials (Y-NEXT), Yokohama City University Hospital, Yokohama, Japan; Department of Neurosurgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

出版信息

J Stroke Cerebrovasc Dis. 2023 Oct;32(10):107291. doi: 10.1016/j.jstrokecerebrovasdis.2023.107291. Epub 2023 Aug 12.

DOI:10.1016/j.jstrokecerebrovasdis.2023.107291
PMID:37579641
Abstract

OBJECTIVES

Chronic subdural hematoma (cSDH) is a common central nervous system condition. Recent reports indicate that cSDH affects long-term prognosis; however, its definitive risk factors remain unknown. An antihypertensive drug, renin-angiotensin-aldosterone system inhibitors (RAASi), can affect vascular permeability and cell proliferation processes, which may suppress the recurrence of cSDH. However, several studies have reported negative results to this effect. Therefore, we aimed to evaluate antihypertensive drugs, including RAASi, as risk factors for recurrent cSDH.

MATERIALS AND METHODS

A total of 203 consecutive cases of surgically treated cSDH were retrospectively reviewed. Clinical and radiological parameters were compared between the groups with and without cSDH recurrence to identify risk factors.

RESULTS

Of the included cases, 68 (33.5%) used RAASi and 37 (18.2%) developed recurrence within 60 days of surgery. In the multiple logistic regression analysis adjusted by composite risk score, the odds ratios (95% confidence interval) of RAASi, calcium channel blockers, diuretics, β and α blockers, for the recurrent risk of cSDH after surgery were 2.49 (1.16, 5.42), 1.79 (0.84, 3.82), 1.83 (0.62, 4.87), 0.90 (0.28, 2.44), and 0.96 (0.21, 3.20), respectively. The Cox proportional hazard model also demonstrated that RAASi-use was an independent risk factor for cSDH recurrence.

CONCLUSIONS

Present series suggests RAASi-use as a risk factor for cSDH recurrence, although the role of RAASi-use in cSDH remains debatable. Further studies for deeper understanding of the microenvironment of hematoma and the surroundings are preferable. (235 words).

摘要

相似文献

1
Renin-angiotensin-aldosterone system inhibitors as a risk factor for chronic subdural hematoma recurrence: A matter of debate.
J Stroke Cerebrovasc Dis. 2023 Oct;32(10):107291. doi: 10.1016/j.jstrokecerebrovasdis.2023.107291. Epub 2023 Aug 12.
2
Predictive factors for recurrence and clinical outcomes in patients with chronic subdural hematoma.慢性硬脑膜下血肿患者复发的预测因素和临床转归。
J Neurosurg. 2017 Nov;127(5):1117-1125. doi: 10.3171/2016.8.JNS16867. Epub 2016 Dec 16.
3
Prevalence of and risk factors for recurrence of chronic subdural hematoma.慢性硬膜下血肿的复发率及危险因素
Acta Neurochir (Wien). 2018 May;160(5):893-899. doi: 10.1007/s00701-018-3513-0. Epub 2018 Mar 12.
4
Endoscopically Observed Outer Membrane Color of Chronic Subdural Hematoma and Histopathological Staging: White as a Risk Factor for Recurrence.内镜下观察慢性硬脑膜下血肿的外膜颜色与组织病理学分期:白色是复发的危险因素。
Neurol Med Chir (Tokyo). 2020 Mar 15;60(3):126-135. doi: 10.2176/nmc.oa.2019-0203. Epub 2020 Jan 3.
5
Time to and Possible Risk Factors for Recurrence after Burr-hole Drainage of Chronic Subdural Hematoma: A Subanalysis of the cSDH-Drain Randomized Controlled Trial.慢性硬脑膜下血肿钻孔引流术后复发时间及可能的危险因素:cSDH-Drain 随机对照试验的亚组分析。
World Neurosurg. 2019 Dec;132:e283-e289. doi: 10.1016/j.wneu.2019.08.175. Epub 2019 Aug 31.
6
Preoperative elevated eosinophils in peripheral blood for prediction of postoperative recurrence of chronic subdural hematoma.术前外周血嗜酸性粒细胞升高预测慢性硬脑膜下血肿术后复发。
J Neurosurg. 2023 Jan 13;139(3):708-713. doi: 10.3171/2022.12.JNS222432. Print 2023 Sep 1.
7
The Danish Chronic Subdural Hematoma Study-Risk Factors for Second Recurrence.丹麦慢性硬脑膜下血肿研究 - 第二次复发的风险因素。
World Neurosurg. 2022 Dec;168:e178-e186. doi: 10.1016/j.wneu.2022.09.072. Epub 2022 Sep 21.
8
Extensive postoperative subdural fluid volume affects the onset of chronic subdural hematoma after unruptured aneurysmal clipping surgery.广泛的术后硬膜下液体积聚影响未破裂动脉瘤夹闭手术后慢性硬膜下血肿的发生。
Clin Neurol Neurosurg. 2019 Dec;187:105533. doi: 10.1016/j.clineuro.2019.105533. Epub 2019 Sep 28.
9
Acute intracranial bleeding and recurrence after bur hole craniostomy for chronic subdural hematoma.慢性硬膜下血肿钻孔引流术后的急性颅内出血及复发
J Neurosurg. 2015 Jul;123(1):65-74. doi: 10.3171/2014.12.JNS141189. Epub 2015 Feb 13.
10
Recurrence in 787 Patients with Chronic Subdural Hematoma: Retrospective Cohort Investigation of Associated Factors Including Direct Oral Anticoagulant Use.787例慢性硬膜下血肿患者的复发情况:包括使用直接口服抗凝剂在内的相关因素的回顾性队列研究
World Neurosurg. 2018 Oct;118:e87-e91. doi: 10.1016/j.wneu.2018.06.124. Epub 2018 Jun 23.

引用本文的文献

1
The impact of renin-angiotensin-aldosterone system inhibitors on the recurrence of chronic subdural hematoma: a systematic review and meta-analysis.肾素-血管紧张素-醛固酮系统抑制剂对慢性硬脑膜下血肿复发的影响:系统评价和荟萃分析。
Neurosurg Rev. 2024 Oct 24;47(1):818. doi: 10.1007/s10143-024-03068-7.